References
Turpin A, El Amrani M, Zaanan A. Localized small bowel adenocarcinoma management: evidence summary. Cancers. 2022;14(12):2892.
Rizzo A, Dadduzio V, Lombardi L, Ricci AD, Gadaleta-Caldarola G. Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges. Curr Oncol. 2021;28(5):3393–402.
National Comprehensive Cancer Network. Ampullary Adenocarcinoma. 2022; https://www.nccn.org/professionals/physician_gls/pdf/ampullary.pdf. Accessed 13 Dec 2022.
National Comprehensive Cancer Network. Small Bowel. 2022; https://www.nccn.org/professionals/physician_gls/pdf/small_bowel.pdf. Accessed 13 Dec 2022.
Zhang C, Lizalek JM, Dougherty C, Westmark DM, Klute KA, Reames BN. Neoadjuvant therapy for duodenal and ampullary adenocarcinoma—a systematic review. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14531-y.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article refers to: Zhang C, Lizalek JM, Dougherty C, Westmark DM, Klute KA, Reames BN. Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma – A Systematic Review. Annals Surgical Oncology. (2023). https://doi.org/10.1245/s10434-023-14531-y.
Rights and permissions
About this article
Cite this article
Zhang, C., Reames, B.N. ASO Author Reflections: Neoadjuvant Therapy for Ampullary and Duodenal Adenocarcinoma—What Do We Know?. Ann Surg Oncol 31, 808–809 (2024). https://doi.org/10.1245/s10434-023-14625-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14625-7